慢性阻塞性肺疾病评估方法的研究进展(3)
参考文献：
[1]Vestbo J，Hurd SS，Agusti AG，et al. Global strategy for the diagnosis， management， and prevention of chronic obstructive pulmonary disease： GOLD Executive Summary[J].Am J Respir Crit Care Med， 2013， 187 (4) ：347 -365.
[2]Deborah H，Colma A， James P， et al. Framework for COPD forecastting in the UK using weather and climate change predictions[J].Earth Environ Sci，2009，6(14) ：142 -144
[3]Martinez FJ，Donohue JF，Rennard SI.The future of chronic obstru- ctive pulmonary disease treatment--difficulties of and barriers to drug de- velopment[J].Lancet，2011，378：1027-1037.
, 百拇医药
[4]Han MK，Agusti A， Calverley PM，et a1. Chronic obstructive pulm- onary disease phenotypes：the future of COPD[J].Am J Respir Crit Care Med，2010，182：598-604.
[5]Vestbo J，Rennard S.Chronic obstructive pulmonary disease biomar- ker(s) for disease activity needed--urgently[J].Am J Respir Crit Care Med，2010，182：863-864.
[6]Fallah Tafti S， Cheraghvandi A， Marashian M， et al. Measurement of the validity and reliability of the Persian translation of the saint george respiratory questionnaire for patients with chronic obstructive pulmonary disease[J].Open Respir Med J， 2009， 3： 107-111.
, http://www.100md.com
[7]Xu w， Collet JP， Shapiro S， et a1.Validation and clinical interpreta- tion of the St George's Respiratory Questionnaire among COPD patients， China[J].Int J Tuberc Lung Dis，2009，13： 181-189.
[8]陆慰萱，张一杰，胡波，等.应用St George's呼吸问卷评价我国慢性阻塞性肺疾病患者生活质量的价值[J].中华结核和呼吸杂志，2003，26：195-198.
[9]Jones PW，Tabberer M，Chen WH.Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test(CATTM) scores[J].BMC Pulm Med，2011，11：42.
, 百拇医药
[10]TOUWEN I.DE WEERT-VAN OENE G H，BOURBEAU J， et a1.Detecting exacerbations using the Clinical COPD Questionnaire [J].Health Qual Life Outcomes，2011，8(1)：102.
[11]Tsiligianni IG，van der Molen T，Moraitaki D，et a1.Assessing health status in COPD.A head-to-head comparison between the COPD assess- ment test(CAT) and the clinical COPD questionnaire(CCQ)[J].BMC Pulm Med，2012，12：20.
[12]Jones PW，Harding G，Wiklund I，et a1.Improving the process and outcome of care in COPD：development of a standardised assessment tool[J]. Prim Care Respir J，2009，18(3)：208-215.
, 百拇医药
[13]Jones PW，Harding G，Berry P，et a1.Development and first validation of the COPD Assessment Test[J].Eur Respir J，2009，34(3)：648-654.
[14]Tsuda T，Suematsu R，Kamohara K，et a1.Development of the Japanese version of the COPD Assessment Test[J].Respir Investig，2012，50(2)：34-39.
[15]Raghavan N，Lam YM，Webb KA，et a1.Components of the COPD Assessment Test(CAT) associated with a diagnosis of COPD in a random population sample[J].COPD，2012，9(2)：175-183.
, 百拇医药
[16]Jones PW，Chen WH，Wilcox TK， et a1.Characterizing and quanti- fying the symptomatic features of COPD exacerbations[J].Chest，2011，139(6)：1388-1394.
[17]Mackay AJ，Donaldson GC，Patel AR，et a1.Detection and severity grading of COPD exacerbations using the exacerbations of Chronic Obst- ructive Pulmonary Disease Tool(EXACT) [J].Eur Respir J，2013 ， 29.
编辑/金昊天, 百拇医药(高志欣 贠相华)
[1]Vestbo J，Hurd SS，Agusti AG，et al. Global strategy for the diagnosis， management， and prevention of chronic obstructive pulmonary disease： GOLD Executive Summary[J].Am J Respir Crit Care Med， 2013， 187 (4) ：347 -365.
[2]Deborah H，Colma A， James P， et al. Framework for COPD forecastting in the UK using weather and climate change predictions[J].Earth Environ Sci，2009，6(14) ：142 -144
[3]Martinez FJ，Donohue JF，Rennard SI.The future of chronic obstru- ctive pulmonary disease treatment--difficulties of and barriers to drug de- velopment[J].Lancet，2011，378：1027-1037.
, 百拇医药
[4]Han MK，Agusti A， Calverley PM，et a1. Chronic obstructive pulm- onary disease phenotypes：the future of COPD[J].Am J Respir Crit Care Med，2010，182：598-604.
[5]Vestbo J，Rennard S.Chronic obstructive pulmonary disease biomar- ker(s) for disease activity needed--urgently[J].Am J Respir Crit Care Med，2010，182：863-864.
[6]Fallah Tafti S， Cheraghvandi A， Marashian M， et al. Measurement of the validity and reliability of the Persian translation of the saint george respiratory questionnaire for patients with chronic obstructive pulmonary disease[J].Open Respir Med J， 2009， 3： 107-111.
, http://www.100md.com
[7]Xu w， Collet JP， Shapiro S， et a1.Validation and clinical interpreta- tion of the St George's Respiratory Questionnaire among COPD patients， China[J].Int J Tuberc Lung Dis，2009，13： 181-189.
[8]陆慰萱，张一杰，胡波，等.应用St George's呼吸问卷评价我国慢性阻塞性肺疾病患者生活质量的价值[J].中华结核和呼吸杂志，2003，26：195-198.
[9]Jones PW，Tabberer M，Chen WH.Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test(CATTM) scores[J].BMC Pulm Med，2011，11：42.
, 百拇医药
[10]TOUWEN I.DE WEERT-VAN OENE G H，BOURBEAU J， et a1.Detecting exacerbations using the Clinical COPD Questionnaire [J].Health Qual Life Outcomes，2011，8(1)：102.
[11]Tsiligianni IG，van der Molen T，Moraitaki D，et a1.Assessing health status in COPD.A head-to-head comparison between the COPD assess- ment test(CAT) and the clinical COPD questionnaire(CCQ)[J].BMC Pulm Med，2012，12：20.
[12]Jones PW，Harding G，Wiklund I，et a1.Improving the process and outcome of care in COPD：development of a standardised assessment tool[J]. Prim Care Respir J，2009，18(3)：208-215.
, 百拇医药
[13]Jones PW，Harding G，Berry P，et a1.Development and first validation of the COPD Assessment Test[J].Eur Respir J，2009，34(3)：648-654.
[14]Tsuda T，Suematsu R，Kamohara K，et a1.Development of the Japanese version of the COPD Assessment Test[J].Respir Investig，2012，50(2)：34-39.
[15]Raghavan N，Lam YM，Webb KA，et a1.Components of the COPD Assessment Test(CAT) associated with a diagnosis of COPD in a random population sample[J].COPD，2012，9(2)：175-183.
, 百拇医药
[16]Jones PW，Chen WH，Wilcox TK， et a1.Characterizing and quanti- fying the symptomatic features of COPD exacerbations[J].Chest，2011，139(6)：1388-1394.
[17]Mackay AJ，Donaldson GC，Patel AR，et a1.Detection and severity grading of COPD exacerbations using the exacerbations of Chronic Obst- ructive Pulmonary Disease Tool(EXACT) [J].Eur Respir J，2013 ， 29.
编辑/金昊天, 百拇医药(高志欣 贠相华)